MyAverix Finance
SHE · Healthcare
Guangdong Taienkang Pharmaceutical Co. Ltd (301263)
Drug Manufacturers - Specialty & Generic
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $11.03B, P/E ratio is 432.00, net margin is 3.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301263
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — FAQ
What is Guangdong Taienkang Pharmaceutical Co. Ltd's market cap?
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a reported market cap of $11.03B (data as of 2026-03-29).
What is 301263's P/E ratio?
The price-to-earnings (P/E) ratio for Guangdong Taienkang Pharmaceutical Co. Ltd (301263) is 432.00 (data as of 2026-03-29).
Does Guangdong Taienkang Pharmaceutical Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Guangdong Taienkang Pharmaceutical Co. Ltd (301263). Check the MyAverix Finance app for the latest dividend data.
What sector is Guangdong Taienkang Pharmaceutical Co. Ltd in?
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301263 listed on?
301263 is listed on SHE.
What is Guangdong Taienkang Pharmaceutical Co. Ltd's net margin?
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) reports a net margin of 3.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.